FDA Investigator Katherine L Arnold
Katherine L Arnold has conducted inspections on 118 sites in 1 countries as of 21 Apr 2014. See below for a list of the FDA enforcement documents resulting from those inspections.
Investigator Details
Number of Inspected Sites:
118
Last Inspection Date:
21 Apr 2014
Investigator Role:
FDA Investigator
Redica ID:
Countries of Inspections:
United States of America
FDA Investigators that have inspected at least one site in common with Katherine L Arnold:
Aaron J Poloni,
Abby M Miller,
Alan D Grupe,
Alicia Aborg Borm,
Alicia M Weitzel,
Amber M Howell,
Amy R Glynn,
Andrew K Haack, PhD,
Andrew S Johnson,
Anh Trinh T Nguyen,
Arie R Dyk,
Avery J Dennis,
Barbara J Rincon,
Barbara R Pfrunder,
Brenda K Alford,
Brenda L Reihing,
Bruce R Burrell,
Bryce E Mansfield,
Camille Bennett Hoffman,
Catherine J Laufmann,
Ce'nedra M Martin,
Christopher E Rezendes,
Christopher R Czajka,
Christopher S Genther,
Clint R Van Blaricom,
Crystal A Harlan,
Cynthia L Gorveatt,
Dan C Fisher,
Dan G Eisenbrey,
Daniel A Congdon,
David A Quale,
David J Gomes,
David L Hunsaker,
Dawn E Barkans,
Deborah A Nebenzahl,
Debra D Devlieger,
Dennis R Hudson,
Devon M Shoop,
Dirk L Lincoln,
Donald B Mckechnie,
Douglas J Scott,
Elizabeth S Howell,
Eric C Milstead,
Eric L Scott,
Eric S Myskowski,
Gavin W Pierce,
Gerard Pde Leon,
Gina C Collins,
Gloria J Baca, MS,
Gordon T Wales,
Graham N Giesen,
Harmon M Blanch,
Heika R Tait,
Hugh A Grimoldby,
Hughes,
Ian J Thomson,
Jack L Christy,
Jacob N Hamilton,
James E Trabert,
James I Vik,
James S Cartwright,
Jane M Kreis,
Janelle K Martin,
Jean C Colon Lopez,
Jean R Mccurry,
Jeanne M Weishaar,
Jeannine K Wooten,
Jeffrey J Leclair,
Jeffrey N Gerdes,
Jennifer W Cheng Dobson,
Jessica B Clark,
Jessica L Kocian,
Jessie J Deloach,
Jinkee Mvila Binayug,
John E Emmert,
John W Banks,
Jonathan T Little,
Jose O Caraballo Rivera,
Joseph M Hudak,
Julia E Chervoni,
Julian C Hanson,
Julie A Stocklin,
Kaitlyn R Kornberg,
Katherine L Ernest,
Kathryn A Krentz,
Keegan B Mixon,
Keishla M Arroyo Lopez,
Kelsey A Hustedt,
Kelsey A Volkman,
Kelsey M Bishop,
Kenneth A Glatt,
Kenneth O Gee, PhD,
Kevin T Gerrity,
Khamphet T Nabe,
Kimberly Jproctor Jones,
Kristen L Demaio,
Kristen L Kamas,
Lance W Bohm,
Laura E Hausch,
Lauren E Swantko,
Lawrence Y Lee, PhD,
LCDR Ismael Olvera, IV,
Lenita R Silvera,
Leon R Marquart,
Lesley A Swanson,
Leya A Grosch,
Lisa A Bowden,
Lisa K Capron,
Lon A Cummings,
Lori J Silverstein,
Lynda L Perry, PhD,
Margo C Jones,
Marijo B Kambere, PhD,
Mark E Imsland,
Mark E Moen,
Mark L Collins,
Mark W Babbitt,
Marsha L Mccauley,
Michael F Schuette,
Michael J Donovan,
Michael S Hudson,
Michael S Valenzuela,
Mikel T Wright,
Nancy E Byerly,
Nancy E Doyle,
Narahi J Alvarez Alcazar,
Neil J Traaen,
Ngoc Lan T Nguyen,
Orval D Mcintire,
Paul F Rader,
Paul M Kawamoto,
Paula J Wilkerson,
Peter Kessler, PhD,
Peter T Regan,
Philip E Ake,
Rachel J Cantrell,
Rebecca A Sletner,
Rebecca T Davis,
Richard G Runyon,
Robert F Hennes,
Robert J Vezzetti,
Rocco C Black,
Ronald E Gill,
Ronald L Lahti,
S Lori Brown, PhD MPH,
Sandra K Wangen,
Sangeeta M Khurana, PhD,
Scott W Fox,
Shahriar Rahmani,
Shannon J Hall,
Sharon I Gundersen,
Sharon K Ferguson,
Shelagh D Schopen,
Sherryl Stoltenow,
Stanley B Eugene, BS, BME,
Stephanie A Slater, MS,
Stephen L Manza,
Sunitha K Rajaram, PhD,
Sunny R Muir,
Tara A Marshall,
Tara M Pianko,
Thomas C Mclean, CFS,
Timothy S Williamson,
Vanessa Y Gelsey, PhD,
Victor A Meo,
Vitaliy N Guyvan,
Wayne F Larson,
Wilfred J Omoloh,
Willis L Hicks,
Xiaojun Yan,
Yvonne M Larsen
Katherine L Arnold's Documents
Publish Date | Document Type | Title |
---|---|---|
June, 2011 | FDA 483 | Wilcox Farms, Inc. - Form 483, 2011-06-06 |
May, 2011 | FDA 483 | Willamette Egg Farms, LLC dba Dybvad Ranch - Form 483, 2011-05-05 |
January, 2011 | FDA 483 | Giant Greens, Inc. - Form 483, 2011-01-21 |
Experience Redica Systems’ NEW investigator profiles and dashboards
Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:
- Total inspections conducted
- 483 rate
- OAI rate
- Warning Letter rate
- Inspections by Industry, Scope, and Inspection Reason
- And much more
Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.
![FDA Investigator Profile Icon](/images/InspectorProfile.png)
Talk to sales to access our investigator profiles
Loading...
Investigator Profiles Are Just the Tip of the Iceberg
Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:
Inspection Intelligence
- Pre-Approval Inspection (PAI) trends
- The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
- Latest 483s: see what the trends are across all FDA Investigators
- CFR Heatmap: Citations aggregated by Subpart by Year
Vendor Intelligence
- Full inspection histories for your vendors down to the specific site level
- All of the functionality mentioned above but isolated to just your vendors
Regulatory Intelligence
- Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
- All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more